Targeting castrate-tolerant prostate cancer cells

Project: Research

Status	Finished
Effective start/end date	24/04/16 → 23/04/20

Hidden clues in prostate cancer – Lessons learned from clinical and pre-clinical approaches on diagnosis and risk stratification
Toivanen, R., Porter, L. H., Li, Z., Clouston, D., Risbridger, G. P. & Taylor, R. A., 1 Jan 2022, In: Cancer Letters. 524, p. 182-192 11 p.
Research output: Contribution to journal › Article › Research › peer-review

3 Citations (Scopus)
Neuroendocrine cells in prostate cancer correlate with poor outcomes: a systematic review and meta-analysis
Kannan, A., Clouston, D., Frydenberg, M., Ilic, D., Karim, M. N., Evans, S. M., Toivanen, R., Risbridger, G. P. & Taylor, R. A., Oct 2022, In: BJU International. 130, 4, p. 420-433 14 p.
Research output: Contribution to journal › Review Article › Research › peer-review

5 Citations (Scopus)
New approaches to targeting epigenetic regulation in prostate cancer
Thompson, D., Choo, N., Bolton, D. M., Lawrentschuk, N., Risbridger, G. P., Lawrence, M. G. & Taylor, R. A., Sep 2022, In: Current Opinion in Urology. 32, 5, p. 472-480 9 p.
Research output: Contribution to journal › Review Article › Research › peer-review

3 Citations (Scopus)

Project Details